期刊文献+

血清降钙素原在慢性阻塞性肺疾病急性加重期患者的表达水平及其临床意义 被引量:9

Expression Level and Its Clinical Significance of Serum Procalcitonin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients
下载PDF
导出
摘要 目的探讨血清降钙素原(PCT)在慢性阻塞性肺疾病急性加重期(AECOPD)患者中的表达水平及其临床意义。方法入选我院2010年10月至2012年10月的AECOPD患者50例,根据用药依据不同分为两组各25例,对照组根据患者情况由临床医师经验性使用抗生素,观察组根据PCT水平使用抗生素。观察两组患者PCT水平的变化,治疗有效率和抗生素的使用情况。结果观察组临床有效率88.0%(22/25)高于对照组80.0%(20/25),但组间差异无统计学意义(P>0.05);治疗4 d、7 d和10 d时,观察组PCT表达均显著低于对照组,抗生素的使用时间和产生的医疗费用均显著低于对照组,差异均具有统计学意义(均P<0.05)。结论 AECOPD患者的PCT表达明显升高,且监测PCT可以指导临床使用抗生素。 Objective To explore the expression level and its clinical significance of serum procalcitonin (PCT) in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients. Methods Fifty patients with AECOPD in our hospital from October 2010 to October 2012 were selected in this study and divided into two groups according prescription basis, with 25 cases in each group. Patients in control group treated with antibiotics based on the experience of clinicians, while patients in observation group were treated with antibiotics based on PCT level. The change of PCT level, treatment effective rate and use condition of antibiotics of two groups were observed. Results The clinical efficiency was 88.0% in observation group, higher than 80.0% in control group, but the difference was not statistically significant :(_P 〉0.05). At 4 d, 7 d, and 10 d of treatment, the PCT levels of observation group were significantly lower than those of control group correspondingly (P 〈0.05). The use time and medical expenses of observation group were significantly lower than those of control group (P 〈0.05). Conclusions The PCT expression is significantly increased in patients with AECOPD. Monitoring PCT can guide the clinical use of antibiotics.
作者 徐志 黄忠毅
出处 《临床医学工程》 2014年第3期321-322,共2页 Clinical Medicine & Engineering
关键词 慢性阻塞性肺疾病急性加重期 降钙素原 抗生素 Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Procalcitonin (PCT) Antibiotics
  • 相关文献

参考文献8

二级参考文献74

共引文献1957

同被引文献84

  • 1骆仙芳,沈华浩.慢性阻塞性肺疾病与肺血管系统[J].国外医学(呼吸系统分册),2005,25(6):433-435. 被引量:13
  • 2常春,姚婉贞,陈亚红,刘振英,张晓伟.血清降钙素原对慢性阻塞性肺疾病加重期患者下呼吸道细菌感染的诊断价值[J].北京大学学报(医学版),2006,38(4):389-392. 被引量:50
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1789
  • 5Krisofferson KB,Sogaard OS,Wejse C,et al.Antibiotic treat- ment interruption of suspected lower respiratory tract infectious based on a single procalcitonin measurement at hospital admission-a randomized trial [J .Clin Microbial Infect, 2009, 15(5 ) :481-487.
  • 6Briel M, Schuetz P, Mueller B, et al. Proealcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med, 2008, 168: 2000- 2007.
  • 7Assicot M, Gendrel D, Carsin H, et al. High serum proealcitonin concentrations in patients with sepsis and infection. Lancet, 1993, 341:515-518.
  • 8Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single- blinded intervention trial, l.ancet,2004,363:600-607.
  • 9Wilson R, Jones P, Schaberg T, et al. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax,2006,61:337-342.
  • 10Lacoma A, Prat C, Andreo F, et al. Value of procalcitonin, C- reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2011,6 : 157-169.

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部